Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's Chorea

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ben Pazi, Hilla ^a   Stoner, Julie A ^b   Cunningham, Madeleine W ^c  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTREPTOLYSIN; AUTOANTIBODY; DOPAMINE D1 RECEPTOR AUTOANTIBODY; DOPAMINE D2 RECEPTOR AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOIMMUNITY; BEHAVIOR CHANGE; CHILD; CHOREA MINOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERACTIVITY; IRRITABILITY; MALE; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRESCHOOL CHILD; PROMINENT TONGUE; SCHOOL CHILD; SIGNAL TRANSDUCTION; SYMPTOM; UFMG SYDENHAM CHOREA RATING SCALE; WALKING;

ADOLESCENT; ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOREA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PROGNOSIS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84884490062     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073516     Document Type: Article

References (27)

1. Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amaral SV, (1999) Persistent Sydenham's chorea. Mov Disord 14: 805-807.
2. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, et al. (2002) Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 59: 227-231.
3. Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE, (2005) Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 20: 424-429.
4. Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, et al. (2011) Extrastriatal dopamine D(2) receptor binding in Huntington's disease. Hum Brain Mapp 32: 1626-1636.
5. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW, (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9: 914-920.
6. Kirvan CA, Cox CJ, Swedo SE, Cunningham MW, (2007) Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol 178: 7412-7421.
7. Brimberg L, Benhar I, Mascaro-Blanco A, Alvarez K, Lotan D, et al. (2012) Behavioral, Pharmacological, and Immunological Abnormalities after Streptococcal Exposure: A Novel Rat Model of Sydenham Chorea and Related Neuropsychiatric Disorders. Neuropsychopharmacology.
8. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, et al. (2012) Antibodies to surface dopamine 2 receptor in autoimmune basal ganglia disorders. Brain Accepted for publication.
9. Teixeira AL Jr, Maia DP, Cardoso F, (2005) UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency. Mov Disord 20: 585-591.
10. Kirvan CA, Swedo SE, Snider LA, Cunningham MW, (2006) Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 179: 173-179.
11. Dale RC, Heyman I, Giovannoni G, Church AW, (2005) Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry 187: 314-319.
12. Swedo SE, (1994) Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. Jama 272: 1788-1791.
13. Leckman JF, King RA, Gilbert DL, Coffey BJ, Singer HS, et al. (2011) Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 50: 108-118 e103.
14. Pena J, Mora E, Cardozo J, Molina O, Montiel C, (2002) Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients. Arq Neuropsiquiatr 60: 374-377.
15. Boyce S, Rupniak NM, Steventon MJ, Iversen SD, (1990) Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. Neurology 40: 927-933.
16. Rascol O, Nutt JG, Blin O, Goetz CG, Trugman JM, et al. (2001) Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch Neurol 58: 249-254.
17. Danek A, Uttner I, Vogl T, Tatsch K, Witt TN, (1994) Cerebral involvement in McLeod syndrome. Neurology 44: 117-120.
18. Brooks DJ, Ibanez V, Playford ED, Sawle GV, Leigh PN, et al. (1991) Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study. Ann Neurol 30: 166-171.
19. Iravani MM, Tayarani-Binazir K, Chu WB, Jackson MJ, Jenner P, (2006) In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\increased motor disability. J Pharmacol Exp Ther 319: 1225-1234.
20. Hasbi A, O'Dowd BF, George SR, (2011) Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain 4: 26.
21. Usiello A, Baik J-H, Rouge-Pont F, Picetti R, Dierich A, et al. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
22. Beaulieu J-M, Gainetdinov RR, (2011) The Physiology, Signaling, and Pharmacology of Dopamine Receptors. Pharmacological Reviews 63: 182-217.
23. Hoffman KL, Rueda Morales RI, (2012) D1 and D2 dopamine receptor antagonists decrease behavioral bout duration, without altering the bout's repeated behavioral components, in a naturalistic model of repetitive and compulsive behavior. Behav Brain Res 230: 1-10.
24. Olver JS, O'Keefe G, Jones GR, Burrows GD, Tochon-Danguy HJ, et al. (2010) Dopamine D(1) receptor binding in the anterior cingulate cortex of patients with obsessive-compulsive disorder. Psychiatry Res 183: 85-88.
25. Ben-Pazi H, Sadan O, Offen D (2011) Striatal Microinjection of Sydenham Chorea Antibodies: Using a Rat Model to Examine the Dopamine Hypothesis. Journal of Molecular Neuroscience: 1-5.
26. Husby G, v de Rijn I, Zabriskie JB, Ardin ZH, Williams RC Jr, (1977) Anti-neuronal antibody in Sydenham's chorea. Lancet 1: 1208.
27. Yaddanapudi K, Hornig M, Serge R, De Miranda J, Baghban A, et al. (2010) Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 15: 712-726.